Wave Life Sciences (WVE) Share-based Compensation (2015 - 2026)

Wave Life Sciences' Share-based Compensation history runs 12 years deep, the most recent figure standing at $9.1 million for Q1 2026.

• Quarterly Share-based Compensation rose 82.98% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.1 million (up 91.17% YoY) and the FY2025 annual result came in at $25.0 million, up 90.04% from the prior year.
• Share-based Compensation was $9.1 million for Q1 2026 at Wave Life Sciences, up from $7.4 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $9.1 million in Q1 2026 and bottomed at -$2.3 million in Q4 2022.
• A 5-year average of $4.1 million and a median of $3.5 million in 2024 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation tumbled 161.22% — and 2023, when it surged 203.11%.
• Wave Life Sciences' Share-based Compensation stood at -$2.3 million in 2022, then jumped by 203.11% to $2.4 million in 2023, then soared by 37.93% to $3.2 million in 2024, then soared by 126.63% to $7.4 million in 2025, then grew by 23.27% to $9.1 million in 2026.
• Business Quant data shows WVE's Share-based Compensation at $9.1 million in Q1 2026, $7.4 million in Q4 2025, and $6.5 million in Q3 2025.